Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (TIAN SP)
1
Analysis
Health Care • China
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited produces and sells traditional Chinese medicine, western medicine, health products, and healthcare instruments. The Group also manufactures gene-related biopharmaceutical products. Tianjin Zhongxin markets its products under the Great Wall, Cypress, and Health brand names.
Location:The Board proposes to convene the AGM for FY2024 at the meeting room of Da Ren Tang Mansion, Nankai District, Tianjin, the PRC 300193 (concurrently, a video conferencing at RNN Conference Centre, GB Building,143 Cecil Street, Level 11, #11-03, Singapore 069542 for holders of the S-Shares in Singapore) on Thursday, 15 May 2025 at 1:30 p.m..
Location:An EGM of the Company will be held at the meeting room of Da Ren Tang Mansion, No. 17 Baidi Road, Nankai District, Tianjin, the PRC 300193 (concurrently, a video conferencing at RNN Conference Centre, 137 Cecil Street, #04-01 Cecil Building, Singapore 069537 for holders of the S-Shares in Singapore) on Monday, 30 December 2024 at 2:00 p.m..
Location:An EGM of the Company will be held at the meeting room of Da Ren Tang Mansion, No. 17 Baidi Road, Nankai District, Tianjin, the PRC 300193 (concurrently, a video conferencing at RNN Conference Centre, 137 Cecil Street, #04-01 Cecil Building, Singapore 069537 for holders of the S-Shares in Singapore) on Monday, 30 December 2024 at 2:00 p.m..
Location:An EGM of the Company will be held at the meeting room of Da Ren Tang Mansion, No. 17 Baidi Road, Nankai District, Tianjin, the PRC 300193 (concurrently, a video conferencing at RNN Conference Centre, 137 Cecil Street, #04-01 Cecil Building, Singapore 069537 for holders of the S-Shares in Singapore) on Monday, 30 December 2024 at 2:00 p.m..
Location:An EGM of the Company will be held at the meeting room of Da Ren Tang Mansion, No. 17 Baidi Road, Nankai District, Tianjin, the PRC 300193 (concurrently, a video conferencing at RNN Conference Centre, 137 Cecil Street, #04-01 Cecil Building, Singapore 069537 for holders of the S-Shares in Singapore) on Monday, 30 December 2024 at 2:00 p.m..